AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

MarketsSign up free
🇿🇦

Lenalidomide in South Africa

40 products registered with SAHPRA — 15 active

Brand / ProductReg. No.HolderStatusExpires
CANCALID 10 mg56/32/0521.514Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
DATRENAL 2,5 mg56/32/0511Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
DATRENAL 7,5 mg56/32/0513Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
CANCALID 7,5 mg56/32/0520.513Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
DATRENAL 5 mg56/32/0512Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
DATRENAL 10 mg56/32/0514Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
DATRENAL 15 mg56/32/0515Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
DATRENAL 20 mg56/32/0516Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
DATRENAL 25 mg56/32/0517Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
CANCALID 2,5 mg56/32/0518.511Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
CANCALID 5 mg56/32/0519.512Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
CANCALID 15 mg56/32/0522.515Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
CANCALID 20 mg56/32/0523.516Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
CANCALID 25 mg56/32/0524.517Aurogen South Africa (Pty) Ltdunknown8 Aug 2028
Adco Lenalidomide 7.5 mg54/32/0549.542Adcock Ingram Limitedsuspended18 Mar 2025
Adco Lenalidomide 2.5 mg54/32/0547.540Adcock Ingram Limitedsuspended18 Mar 2025
Adco Lenalidomide 20 mg54/32/0552.545Adcock Ingram Limitedsuspended18 Mar 2025
Adco Lenalidomide 5 mg54/32/0548.541Adcock Ingram Limitedsuspended18 Mar 2025
Adco Lenalidomide 25 mg54/32/0553.546Adcock Ingram Limitedsuspended18 Mar 2025
Adco Lenalidomide 10 mg54/32/0550.543Adcock Ingram Limitedsuspended18 Mar 2025
Adco Lenalidomide 15 mg54/32/0551.544Adcock Ingram Limitedsuspended18 Mar 2025
REVLIMID 10 mg47/32/0508Key Oncologics (Pty) Ltdsuspended11 Jan 2024
REVLIMID 5 mg47/32/0507Key Oncologics (Pty) Ltdsuspended24 Jan 2023
REVLIMID 25 mg47/32/0510Key Oncologics (Pty) Ltdsuspended24 Jan 2023
REVLIMID 15 mg47/32/0509Key Oncologics (Pty) Ltdsuspended24 Jan 2023
Neoled 15 mg54/32/0544Adcock Ingram Limitedactive1 Jan 1900
LENALIDOMIDE 25 mg FORRESTER54/32/0719Forrester Pharma (Pty) Ltdactive1 Jan 1900
Neoled 7.5 mg54/32/0542Adcock Ingram Limitedactive1 Jan 1900
Neoled 20 mg54/32/0545Adcock Ingram Limitedactive1 Jan 1900
Neoled 5 mg54/32/0541Adcock Ingram Limitedactive1 Jan 1900
Neoled 2.5 mg54/32/0540Adcock Ingram Limitedactive1 Jan 1900
MYELID 555/32/0294Cipla Medpro (Pty) Ltdactive1 Jan 1900
LENALIDOMIDE 10 mg FORRESTER54/32/0716Forrester Pharma (Pty) Ltdactive1 Jan 1900
LENALIDOMIDE 20 mg FORRESTER54/32/0718Forrester Pharma (Pty) Ltdactive1 Jan 1900
LENALIDOMIDE 15 mg FORRESTER54/32/0717Forrester Pharma (Pty) Ltdactive1 Jan 1900
Neoled 10 mg54/32/0543Adcock Ingram Limitedactive1 Jan 1900
Neoled 25 mg54/32/0546Adcock Ingram Limitedactive1 Jan 1900
LENALIDOMIDE 7,5 mg FORRESTER54/32/0715Forrester Pharma (Pty) Ltdactive1 Jan 1900
LENALIDOMIDE 2,5 mg FORRESTER54/32/0713Forrester Pharma (Pty) Ltdactive1 Jan 1900
LENALIDOMIDE 5 mg FORRESTER54/32/0714Forrester Pharma (Pty) Ltdactive1 Jan 1900

Lenalidomide — SAHPRA Registration Details

SAHPRA (South Africa) has 40 registered products containing Lenalidomide, of which 15 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.

Track Lenalidomide registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.